Speaker Profile
Vice President Clinical, Oxford Nanopore
Biography
As Head of Oxford Nanopore Diagnostics (OND), Emma supports Oxford Nanopores ambitions for growth in healthcare applications. Until November 2020, Emma was Director for Supplies and Innovation as part of the British government's NHS Test and Trace response to COVID19. Prior to this, Emma was CEO of Four Eyes Insight, Chief Partnership Officer for Beacon Health Options (Northeast USA) and CEO of Beacon in the UK. Emma has also been a Commonwealth Fund Harkness Fellow in Healthcare Policy and Practice and a Senior Associate at the Institute for Strategy and Competitiveness, both at Harvard University. Prior to this, Emma was a practicing clinician in the UK's National Health Service (NHS).
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation
- Robert Sebra, ISMMS
- Anshul Kundaje, Stanford
- Chaz Langelier, UCSF
- Orly Alter, Prism AI Inc - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF
- Billy Tsz Cheong Lau, Stanford - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - New Frontiers in Genomic Analysis & Interpretation continues: AI in Spatial Transcriptomics in Patient Response
- David. W. Craig, City of Hope Cancer Center
- Premal Shah, MyOme - The Economic Perspective on Genomics (PANEL)
Chair: Bill Hyun, UCSF
- Steve Turner, PacBio
- Alex de Winter, Danaher Ventures
- Kandaswamy (Swamy) Vijayan, Zafrens - Using AI for Scalable Phenotyping and Discovery
- Andrew Carroll, Google
- Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos - NCI Showcase
- Xiaofeng Xie, MicrOmics Technologies
